SC
MRNA icon

Slow Capital’s Moderna MRNA Stock Holding History

Slow Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-27,253
Closed -$1.82M – 123
2024
Q3 		$1.82M Sell
27,253
-4,484
-14% -$412K 0.28% 90
2024
Q2 		$3.77M Sell
31,737
-6,346
-17% -$803K 0.61% 49
2024
Q1 		$4.06M Buy
38,083
+13,718
+56% +$1.38M 0.65% 48
2023
Q4 		$2.42M Buy
24,365
+3,816
+19% +$321K 0.42% 81
2023
Q3 		$2.12M Buy
20,549
+5,637
+38% +$629K 0.39% 82
2023
Q2 		$1.81M Sell
14,912
-363
-2% -$48.4K 0.31% 93
2023
Q1 		$2.35M Buy
15,275
+680
+5% +$112K 0.44% 83
2022
Q4 		$2.62M Buy
14,595
+139
+1% +$22.7K 0.58% 56
2022
Q3 		$1.71M Buy
14,456
+76
+0.5% +$11.5K 0.37% 81
2022
Q2 		$2.05M Buy
14,380
+1,563
+12% +$223K 0.5% 66
2022
Q1 		$2.21M Buy
12,817
+673
+6% +$113K 0.41% 86
2021
Q4 		$3.08M Buy
12,144
+544
+5% +$159K 0.53% 61
2021
Q3 		$4.46M Sell
11,600
-99
-0.8% -$36.5K 0.82% 27
2021
Q2 		$2.75M Buy
11,699
+418
+4% +$74.7K 0.52% 72
2021
Q1 		$1.5M Buy
+11,281
New +$1.63M 0.33% 112

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

Slow Capital's MRNA Position: Q4 2024 in Review

Slow Capital sold out of Moderna (MRNA) in Q4 2024, closing a stake of 27,253 shares — an estimated $1.82M sold.

Slow Capital first reported a position in MRNA in Q1 2021 and held it in 15 quarters. The position peaked at $4.46M in Q3 2021. 745 funds tracked by Wall St. Rank hold MRNA as of Q4 2024.

  • Slow Capital reported no remaining Moderna position as of Q4 2024 after selling out during the quarter.
  • Slow Capital sold 27,253 Moderna shares in Q4 2024, an estimated $1.82M.
  • Slow Capital first reported a position in Moderna in Q1 2021 and held it in 15 quarters.
  • Slow Capital's Moderna position peaked at $4.46M in Q3 2021.
  • 745 funds tracked by Wall St. Rank held Moderna as of Q4 2024.

Based on Slow Capital's 13F filing for Q4 2024, filed 22 Jan 2025.